Adaptimmune Therapeutics plc ADAP
$ 0.66
-2.12%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 13.11.2024
Adaptimmune Therapeutics plc Мультипликаторы 2011-2024 | ADAP
Мультипликаторы по годам Adaptimmune Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-18.0 | -7.6 | -17.3 | -35.9 | -18366.4 | -28509.1 | -65226.8 | -24861.4 | -365.8 | - | - | - | - |
P/S |
34.0 | 46.3 | 443.9 | 1179.2 | 2245294.9 | 45761.2 | 120923.0 | 125338.2 | 736.6 | - | - | - | - |
EPS |
-0.1 | -0.2 | -0.2 | -0.1 | -0.2 | -0.2 | -0.1 | -0.2 | -0.2 | -0.1 | -0.3 | - | - |
EV (Enterprise Value) |
2.15 млрд | 1.4 млрд | 2.84 млрд | 4.72 млрд | 2.52 трлн | 2.72 трлн | 4.57 трлн | 1.78 трлн | 6.25 млрд | 53.1 млн | 3.97 млн | 4.09 млн | - |
EBITDA per Share |
-0.11 | -0.16 | -0.17 | -0.15 | -0.000209 | -0.000128 | -0.000146 | -0.000164 | -0.0427 | - | - | - | - |
EV/EBITDA |
-12.7 | -6.4 | -19119.6 | -36522.7 | -60804.3 | -25598.0 | -343.3 | - | - | - | - | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.0 | 552.58 | 1241.31 | -3087.83 | 104.87 | -4.58 | - | - | - | - |
P/B |
51.9 | 15.4 | 13.3 | 13.7 | 20375.8 | 11029.5 | 22538.1 | 10711.0 | 24.7 | - | - | - | - |
P/CF |
-14.6 | -8.9 | 254.4 | -87.1 | -21796.2 | -24959.8 | -57671.2 | -29195.5 | -208.7 | - | - | - | - |
ROE % |
-288.19 | -202.08 | -76.76 | -38.12 | -110.94 | -38.69 | -34.55 | -43.08 | -6.75 | - | - | - | - |
ROA % |
-40.29 | -50.30 | -33.67 | -28.84 | -75.56 | -34.51 | -24.95 | -30.52 | -7.18 | - | - | - | - |
ROCE % |
-353.66 | -200.26 | -78.78 | -39.10 | -94.95 | -32.65 | -39.00 | -37.48 | -8.42 | - | - | - | - |
Current Ratio |
1.2 | 1.3 | 1.8 | 4.1 | 3.5 | 9.5 | 3.1 | 4.9 | 11.0 | - | - | - | - |
DSO |
25.0 | 55.0 | 26.4 | 6.4 | 6724.5 | 111.4 | 2.0 | 38.0 | 185.4 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
25.0 | 55.0 | 26.4 | 6.4 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
25.0 | 55.0 | 26.4 | 6.4 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Adaptimmune Therapeutics plc
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.01 | 0.05 | -0.03 | - | -0.03 | -0.02 | - | - | -0.04 | -0.05 | -0.05 | - | -0.05 | -0.04 | -0.04 | - | -0.04 | -0.04 | -0.04 | - | -0.06 | -0.07 | -0.04 | - | 0.01 | -0.08 | -0.04 | - | -0.08 | -0.04 | -0.05 | - | -0.04 | -0.05 | -0.04 | - | -0.01 | -0.05 | -0.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.03 | - | - | - | - | - | -0.04 | -0.05 | -0.05 | - | -0.04 | -0.04 | -0.04 | - | -0.03 | -0.03 | -0.04 | - | -0.06 | -0.05 | -0.05 | - | 0.02 | -0.04 | -0.05 | - | -0.01 | -0.04 | -0.05 | - | -0.04 | -0.05 | -0.04 | - | -0.02 | -0.03 | -0.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-200.54 | -230.26 | -319.36 | -67.40 | -103.94 | -88.75 | -103.23 | -98.73 | -116.32 | -97.37 | -80.06 | -43.87 | -54.25 | -47.04 | -41.74 | -27.39 | -59.18 | -80.59 | -105.06 | -87.19 | -85.29 | -51.61 | -36.13 | -24.26 | -24.64 | -26.93 | -17.98 | -19.65 | -30.78 | -41.53 | -46.02 | -31.54 | -34.20 | -25.73 | -18.63 | -18.64 | -18.64 | -15.99 | -9.79 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-18.11 | -27.93 | -55.78 | -21.25 | -33.72 | -30.81 | -36.55 | -36.42 | -48.41 | -35.96 | -45.98 | -31.19 | -39.05 | -34.91 | -31.51 | -20.72 | -42.37 | -56.16 | -72.17 | -59.38 | -57.49 | -33.94 | -27.15 | -21.44 | -21.76 | -23.96 | -15.31 | -15.25 | -23.14 | -30.71 | -32.94 | -23.26 | -25.45 | -19.74 | -15.42 | -15.33 | -15.33 | -13.14 | -8.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-202.00 | -236.57 | -343.38 | -86.40 | -124.33 | -109.35 | -104.72 | -99.40 | -116.90 | -96.47 | -79.79 | -43.90 | -54.42 | -47.43 | -42.15 | -28.10 | -60.55 | -82.49 | -102.34 | -88.50 | -85.95 | -50.96 | -33.95 | -20.80 | -22.96 | -27.67 | -26.34 | -23.19 | -34.40 | -43.44 | -46.74 | -32.55 | -36.09 | -28.42 | -19.48 | -19.50 | -19.50 | -15.97 | -11.24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 1.4 | 1.1 | 1.2 | 1.4 | 1.6 | 1.4 | 1.3 | 1.5 | - | 1.6 | 1.8 | 3.1 | 3.5 | 4.0 | 4.1 | 4.1 | 4.1 | 4.1 | 3.1 | 3.1 | 3.1 | 3.1 | 9.3 | 9.3 | 9.3 | 9.3 | 3.6 | 3.6 | 3.6 | 3.6 | 3.4 | 3.4 | 3.4 | 6.1 | 5.6 | 5.6 | 5.6 | 5.6 | - | - | 1.1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
16.6 | 3.8 | 74.1 | - | 23.4 | 41.7 | 8.8 | - | 11.6 | 15.0 | 32.9 | - | 144.1 | 31.8 | 14.6 | - | 10.6 | 12.6 | - | - | 733.3 | 1106.9 | - | - | 0.4 | 1.9 | 2.2 | - | 0.7 | 5.3 | 26.9 | - | 55.9 | 206.0 | 11.7 | - | 13.7 | 24.4 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
16.6 | 3.8 | 74.1 | - | 23.4 | 41.7 | 8.8 | - | 11.6 | 15.0 | 32.9 | - | 144.1 | 31.8 | 14.6 | - | 10.6 | 12.6 | - | - | 733.3 | 1106.9 | - | - | 0.4 | 1.9 | 2.2 | - | 0.7 | 5.3 | 26.9 | - | 55.9 | 206.0 | 11.7 | - | 13.7 | 24.4 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
16.6 | 3.8 | 74.1 | - | 23.4 | 41.7 | 8.8 | - | 11.6 | 15.0 | 32.9 | - | 144.1 | 31.8 | 14.6 | - | 10.6 | 12.6 | - | - | 733.3 | 1106.9 | - | - | 0.4 | 1.9 | 2.2 | - | 0.7 | 5.3 | 26.9 | - | 55.9 | 206.0 | 11.7 | - | 13.7 | 24.4 | 3.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD